Loading
Scholar Rock Holding Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by AKKARAJU SRINIVAS, was filed 16 Dec 2025.
Insider Decl.
412
Thresholds
n/a
Buy Volume
€62M
23 ops. · all time
Sell Volume
€160M
157 ops. · all time
Who traded when
BuySaleQatanani Mo18 sales
Katie Peng10 sales
Jeffrey S. Flier9 sales
Marantz Jing L.9 sales
Srinivas Akkaraju9 buys
Invus Public Equities, L.P.6 sales
+14 other insiders
Since the insiders bought
- -7.5%Entry US$44.01 · Close at T+90 US$40.71
- +307.3%Entry US$7.50 · Close at T+365 US$30.55
- +233.3%Entry US$8.70 · Close at T+365 US$29.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Scholar Rock Holding Corp Strong Buy (bullish), based on 16 analysts. Average price target: US$70.44.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$43.00
Analyst consensus
16 analystsStrong buy
US$58.00Target US$70.44(+64%)US$84.00
Income statement
EBITDA-US$369.4M
Net income-US$377.9M0.0% margin
Valuation
PER (forward)-17.4x
P/Book20.6x
Beta0.62
Balance sheet & cash
Market capUS$5.2B
Total debtUS$108.9M
Free Cash Flow-US$300.6M
Debt / Equity80%
Profitability & ownership
ROE-167.8%
ROA-58.8%
% insiders0.7%
% institutions117.6%
Last declaration on 1 October 2026
Declarations412 total
1,006 shares@ US$48.32010.0008% mcap14.1% of flowCommonSEC144:0001968582-26-001028
48,034 shares0Common StockSEC:0001104659-26-110976:0
36,652 shares0Common StockSEC:0001104659-26-110006:0
11,704 shares@ US$54.680.011% mcap100.0% of flowCommonSEC144:0001968582-26-000697
2,105 shares@ US$53.4940.0019% mcap11.3% of flowCommon StockSEC:0001193125-26-296248:0
948 shares@ US$54.28160.0008% mcap5.2% of flowCommon StockSEC:0001193125-26-296248:1
1,568 shares@ US$53.53280.0014% mcap6.2% of flowCommon StockSEC:0001193125-26-296252:0
15 shares@ US$54.87570.0000% mcap0.1% of flowCommon StockSEC:0001193125-26-296252:2
2,988 shares@ US$53.55980.0026% mcap33.1% of flowCommon StockSEC:0001193125-26-296245:0
21 shares@ US$54.96410.0000% mcap0.2% of flowCommon StockSEC:0001193125-26-296245:2
2,105 shares@ US$53.49580.0019% mcap36.4% of flowCommon StockSEC:0001193125-26-296247:0
948 shares@ US$54.28140.0008% mcap16.6% of flowCommon StockSEC:0001193125-26-296247:1
1,470 shares@ US$54.23650.0013% mcap5.9% of flowCommon StockSEC:0001193125-26-296252:1
1,346 shares@ US$53.5440.0012% mcap46.4% of flowCommon StockSEC:0001193125-26-296251:0
1,155 shares@ US$54.22570.0010% mcap40.3% of flowCommon StockSEC:0001193125-26-296251:1
43 shares@ US$54.81450.0000% mcap1.5% of flowCommon StockSEC:0001193125-26-296251:2
2,437 shares@ US$54.25260.0022% mcap27.4% of flowCommon StockSEC:0001193125-26-296245:1
3,053 shares@ US$54.790.0028% mcap100.0% of flowCommonSEC144:0001968582-26-000687
3,053 shares@ US$54.790.0028% mcap100.0% of flowCommonSEC144:0001968582-26-000688
2,544 shares@ US$54.78970.0024% mcap100.0% of flowCommonSEC144:0001968582-26-000686
5,446 shares@ US$54.78990.0050% mcap100.0% of flowCommonSEC144:0001968582-26-000685
3,053 shares@ US$54.790.0028% mcap100.0% of flowCommonSEC144:0001968582-26-000689
6,839 shares0Common StockSEC:0001104659-26-071422:0
6,839 shares0Common StockSEC:0001104659-26-071429:0
6,839 shares0Common StockSEC:0001104659-26-071428:0
25 of 412 declarations
About Scholar Rock Holding Corp
Scholar Rock Holding Corp weighs heavily in amounts: 108 sales worth EUR 108.8 million (median EUR 130,705) and 25 purchases worth EUR 63.4 million (median EUR 521,577), or 19% purchases. Invus Public Equities, L.P. sold EUR 63,134,733 on December 10, 2024 and EUR 7,478,625 on November 25, 2024, and Srinivas Akkaraju, a director, EUR 12,778,178 on October 7, 2024.
On the purchase side, Invus Public Equities bought EUR 14,235,901 on October 12, 2023, Samsara BioCapital GP, LLC EUR 14,212,200 on October 16, 2023, and Akkaraju EUR 10,203,032 on October 3, 2025. On May 29, 2018, four insiders bought EUR 9,792,569 in total. Across the full history, 7 purchase filings are classed as clustered.
Read moreShow less
This US healthcare company, valued at USD 4.9 billion and 0.7% held by insiders, has 337 filings from 37 filers, 97 of them of another kind. Amir Nashat, a director, files 53, including 4 purchases. Annual volume rises to 65 in 2025, against 4 in 2019. The last twelve months have 64 filings, 3 purchases and 32 sales. For 22 purchases, the stored 90-day result has a median of -6.8%, with 45% of results positive (recorded past, not a forecast).
